As compared with control siRNA, PKM2 silencing resulted in a remarkable reduction of PKM2 protein and mRNA expression in U-87 MG GBM cells, in TS#163 neurospheres and in RPE-1 non-cancer cells, as evaluated via western blotting and RT-PCR, respectively (Fig. S6). Here, PKM is linked to glioblastoma.